Hyderabad to host BioAsia 2004
By Our Corporate Bureau | 11 Dec 2003
Hyderabad: Hyderabad India has been chosen to be the venue of BioAsia 2004, a global bio-business event, to be held from 26 to 28 February at Hitex City, Hyderabad.
The convenors of the conference say that the Andhra Pradesh state government and Genome Valley in Hyderabad have been playing a pivotal role in showcasing Andhra Pradesh as India's biotech hub through various forums and events. Because of this the organisation has decided to organise the annual biotech event BioAsia in the city.
The event which will be the inaugural one will serve as a unique platform for top management of biotech companies, R&D heads, investors and other biotech professionals to meet with key research and business development representatives from pharmaceutical, agri-biotech and marine sectors, venture capitalists and start-ups, and foods and finance industries.
BioAsia consists of an international conference, tradeshow, B2B forum, knowledge pavilion and a CEO conclave. Over 100 exhibitors, 500 conference delegates, 50 internationally acclaimed speakers and 15,000 visitors from across the globe are expected to attend BioAsia 2004.
The conference theme will be 'Bringing Asian and the Global Biotech Community Together by Bridging the Development Divide'. The conference speakers will include international experts on the topics, who will analyse new industry trends and discuss how biotechnology companies can face current challenges.
The
proposed conference topics are:
-
Biotechnology in Asia: strengths and necessary steps to propel it forward
-
Outsourcing as a destination
-
Building and managing partnerships for future growth in indigenous vaccines
-
A look at the growth perspective in India bioinformatics
-
A vital tool in genomics, agri-biotech and marine biotech
-
Emerging areas — industry, academia, VCs — roundtable
-
The biotech revolution
-
The hope behind the hype — phyto-pharmaceuticals
-
Phenomenal growth area or a utopian obsession?
-
Drug discovery and development — a vision of the future
-
Is personalised medicine real? Can we assimilate and afford the new technology?
-
Governmental responsibilities to the biotech sector
-
The issues concerning Indian biotech stem cell research
